![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
1. Metabolism of adriamycin (ADR) and daunorubicin (DR) was investigated in DBA/2Ha mice after i.p. injection and compared with that in phenobarbital-pretreated animals. At 24h after drug administration 83% of ADR and 67% of Dr derived fluorescence were recovered from cadavers and excreta. Destruction of anthracyclines in excreta to non-fluorescent materials could be partly responsible for the low recoveries.
2. ADR was metabolized to a limited extent in mice. At 24h 70% dose was detected as the unchanged drug and only 13% as its deoxyaglycones.
3. Dr was metabolized more extensively. At 24h 29% of the dose was as the unchanged drug, while 32% was present as daunorubicinol (DROL) and 16% as aglycones. Phenobarbital did not significantly affect these parameters.
4. In phenobarbital-pretreated mice there was a marked increase in the amounts of ADR or DR aglycones in the liver, and a decrease in the levels of unchanged ADR or Dr.